The next public meeting of the National Biodefense Science Board (NBSB) will be held virtually on Thursday, November 30, 2023, from 12:30 to 4:00 p.m. ET.  Advanced registration is required.  To register for the webinar and for additional meeting information, visit the NBSB public meeting page.  We encourage you to share this engagement opportunity broadly across your network.

The NBSB will discuss and vote on two set of recommendations related to COVID-19 pandemic lessons; Project NextGen vaccine and therapeutic products, priorities for future medical countermeasure attributes as requested by the Biomedical Advanced Research and Development Authority; and disaster preparedness training.  Drafts of the recommendations for public review will be on the NBSB webpage as soon as they are available.

Anyone may submit questions or comments to the board members by email to (NBSB@hhs.gov) ahead of the meeting.  If time allows, the NBSB board members will address as many written comments as possible.  Requests to speak during the public meeting should be sent to (NBSB@hhs.gov) by 5:00pm ET on November 23, 2023.  Please provide the speaker’s full name, organization, and a full explanation of the intended topic.  Presentations that contain material with a commercial bias, advertising, marketing, or solicitations will not be allowed.  All meeting materials will be made publicly available on the NBSB public meeting page.  For additional information or questions about this event, please contact (NBSB@hhs.gov).

American Sign Language translation and Communication Access Real-Time Translation will be provided during the meeting.